Screener
Bristol-Myers Squibb BMY Acquired Intangible Amortization
Acquired Intangible Amortization at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept bmy:AmortizationofAcquiredIntangibleAssets.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative | 1,826 | 1,713 | 3,443 | 3,297 |
| Research and development | 2,959 | 2,580 | 5,608 | 4,837 |
| Acquired IPRD | — | 1,508 | 94 | 1,695 |
| Amortization of acquired intangible assets | 437 | 830 | 874 | 1,660 |
| Other (income)/expense, net | (61) | 494 | (28) | 833 |
| Total Expenses | 8,887 | 10,496 | 17,137 | 18,726 |
| Earnings/(Loss) before income taxes | 4,086 | 1,773 | 7,326 | 4,744 |
| Income tax provision | 770 | 460 | 1,331 | 969 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is Bristol-Myers Squibb's acquired intangible amortization?
- Bristol-Myers Squibb (BMY) reported acquired intangible amortization of $437M in Q2 2026.
- How has Bristol-Myers Squibb's acquired intangible amortization changed year-over-year?
- Bristol-Myers Squibb's acquired intangible amortization decreased by 47.3% year-over-year, from $830M to $437M.
- What is the long-term trend for Bristol-Myers Squibb's acquired intangible amortization?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's acquired intangible amortization has grown at a -24.2% compound annual growth rate (CAGR), from $10.02B to $3.32B.
- What does acquired intangible amortization mean?
- This metric represents the systematic allocation of the cost of intangible assets, such as patents and acquired product rights, over their useful lives. It reflects the non-cash expense associated with the historical acquisition of intellectual property.
Ask your AI about Bristol-Myers Squibb's acquired intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude